by Micki Ward | Apr 12, 2024 | AHT Resources, Health Care Reform, Property & Casualty
Psilocybin Microdosing Promising Results for Women Studies have indicated that women are increasingly turning to microdosing on psilocybin to improve their health outcomes. Microdosing involves taking a small dose of the substance to produce mild effects on a regular...
by Micki Ward | Mar 19, 2024 | AHT Resources, News, Property & Casualty
New PTSD Treatment on the Horizon We’re excited to announce that the FDA has granted priority review for a New Drug Application (NDA) for MDMA-assisted therapy for Post Traumatic Stress Disorder (PTSD). This development holds the potential to significantly...
by Taylor Costello | Feb 5, 2024 | AHT Resources, Benefits, Benefits Resources
Off-label Drug Use Cover for weight loss or not? To cover or not is the question many U.S. insurance companies and employers continue to ponder when it comes to obesity medications, such as Wegovy, and diabetes drugs, like Ozempic and Mounjaro, being used off-label...
by Taylor Costello | Feb 5, 2024 | AHT Resources, Benefits, Benefits Resources
Pharmacy Benefit Managers Are they adding value to your health plan? Limited price transparency. Lack of competition. Changing formularies. Spread pricing. These are just some of the issues that employers face with the pharmacy benefit managers (PBM) used to...
by Taylor Costello | Feb 5, 2024 | AHT Resources, Benefits, Benefits Resources
Upskilling for the Silver Tsunami Using AI Fill Skills Gaps Using AI Training Tools Infosys does it. Amazon does it. Even McDonald’s does it. What are these employers doing today that could transform their workforces tomorrow? They have embraced technology,...
by Micki Ward | Dec 13, 2023 | AHT Resources, International Resources, Property & Casualty
That Time of the Year AHT’s Risk and Insurance Benchmarking Report by: Joe Gleason, AHT Director of International Risk Management It’s that time of year again and I’m not talking about the winter holidays – though it is that time of year, too. No, of course I’m...
